Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-18Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities
-
CLINICAL_TRIALS study record update · 2025-12-17Diabetes Medical Nutrition Therapy in Southeastern African American Women
-
CLINICAL_TRIALS study record update · 2025-12-17The Effects of a High Fructose Diet on the Gut Microbiome and Metabolic Health: A Controlled Clinical Intervention Study
-
CLINICAL_TRIALS study record update · 2025-12-17My Diabetes, My Community
-
CLINICAL_TRIALS study record update · 2025-12-17Delivering Evidence Based Care Using Artificial Intelligence to Patients With Diabetes and CardioVascular Comorbidities: The DECIDE-CV Innovation Project
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-16Canagliflozin Attenuates CMR-Quantified Myocardial Fibrosis in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2025-12-16Whey Protein Dose-response Effect on Daily Glycaemic Excursions in Very Old Individuals With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-15Optimizing Delivery of Diabetes Management During Breast Cancer Care
-
CLINICAL_TRIALS study record update · 2025-12-12Adaptive Dietary Intervention (ADI) Leveraging Continuous Glucose Monitoring for Asian Americans With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-12Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
-
CLINICAL_TRIALS study record update · 2025-12-12A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-12Comparative Study of Tirzepatide vs Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-11E3 Diabetes - Closing the Gap in Diabetes Control
-
CLINICAL_TRIALS study record update · 2025-12-09Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-09Evaluation of Correlations Between Volatile Organic Compounds (VOCs) Spectra Measured With GC-IMS and MOx-sensors and Venous Blood Glucose in Subjects With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-09Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases
-
CLINICAL_TRIALS study record update · 2025-12-08Investigation of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics of Single Administrations of NNC9733-0001 in Healthy Participants and in Participants With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-08Carb Control: Low-Carbohydrate Dietary Intervention for Pediatric Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-08A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-12-05An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Two Period, Two Way Crossover, Oral Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets of Humanis Sağlık A.Ş., Ç.O.S.B. Karaağaç Mahallesi Fatih Bulvarı No:32 Kapaklı/TEKİRDAĞ and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets of Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, The Netherlands, in Healthy, Adult, Human Subjects Under Fed Condition.
-
CLINICAL_TRIALS study record update · 2025-12-05A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Phase ⅡStudy to Evaluate the Efficacy and Safety of HRS-7535 in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
-
CLINICAL_TRIALS study record update · 2025-12-05SEMA-CardioDiab HUNGARY: A Multicentre, Prospective, Non-interventional Study to Evaluate Glycemic Control and Weight Changes in Patients With Type 2 Diabetes Initiating Treatment With Oral Semaglutide by Cardiologists or Diabetologists as Part of Local Clinical Practice in Hungary
-
CLINICAL_TRIALS study record update · 2025-12-04Type 2 Diabetes Secondary Prevention Trial at the Reunion Island
-
CLINICAL_TRIALS study record update · 2025-12-04Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes: A Digital Twin Study
-
CLINICAL_TRIALS study record update · 2025-12-04A Dyadic Coping Strategy to Enhance Step Prescription Effects in Type 2 Diabetes: a Bayesian Adaptive Basket Randomized Controlled Trial